We've found
3,204
archived clinical trials in
Healthy Studies
We've found
3,204
archived clinical trials in
Healthy Studies
BMS Reverse Cholesterol Transport (RCT) Study
Updated: 12/31/1969
A Pilot Study to Evaluate the Use of 3H Particulate Cholesterol as a Method to Study Reverse Cholesterol Transport in Humans
Status: Enrolling
Updated: 12/31/1969
BMS Reverse Cholesterol Transport (RCT) Study
Updated: 12/31/1969
A Pilot Study to Evaluate the Use of 3H Particulate Cholesterol as a Method to Study Reverse Cholesterol Transport in Humans
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Safety of USB005 in Healthy Volunteers
Updated: 12/31/1969
Evaluation of USB005 in a Phase 1 Normal, Healthy Volunteer Ocular Safety and PK Study
Status: Enrolling
Updated: 12/31/1969
Study of the Safety of USB005 in Healthy Volunteers
Updated: 12/31/1969
Evaluation of USB005 in a Phase 1 Normal, Healthy Volunteer Ocular Safety and PK Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of LY3154207 in Healthy Participants
Updated: 12/31/1969
Disposition of [14C]-LY3154207 Following Oral Administration in Healthy Male Subjects
Status: Enrolling
Updated: 12/31/1969
Study of LY3154207 in Healthy Participants
Updated: 12/31/1969
Disposition of [14C]-LY3154207 Following Oral Administration in Healthy Male Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Determination of Normal Reference Values of CRP, Procalcitonin, and Lactate Levels for the Nanōmix eLab® System
Updated: 12/31/1969
Evaluation of the Levels of C-Reactive Protein, Procalcitonin, and Lactate in a Normal Healthy Population When Tested With the Nanōmix eLab® System
Status: Enrolling
Updated: 12/31/1969
Determination of Normal Reference Values of CRP, Procalcitonin, and Lactate Levels for the Nanōmix eLab® System
Updated: 12/31/1969
Evaluation of the Levels of C-Reactive Protein, Procalcitonin, and Lactate in a Normal Healthy Population When Tested With the Nanōmix eLab® System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Safety, Tolerability, and Pharmacokinetics of Single Doses of PHP-303 in Healthy Subjects
Updated: 12/31/1969
A Phase 1, Single-Center, Randomized, Double-Blind, Placebo-Controlled Single-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PHP-303 in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
A Study of Safety, Tolerability, and Pharmacokinetics of Single Doses of PHP-303 in Healthy Subjects
Updated: 12/31/1969
A Phase 1, Single-Center, Randomized, Double-Blind, Placebo-Controlled Single-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PHP-303 in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Dose-Ranging, Pharmacokinetic (PK), Glucodynamic (GD), Safety and Tolerability Study of Subcutaneously (SC) Administered Humulin R and Humalog With or Without rHuPH20
Updated: 12/31/1969
A Phase I, Randomized, Dose-Ranging, Pharmacokinetic, Glucodynamic, Safety, and Tolerability Study of SC Administered Humulin R and Humalog With or Without Recombinant Human Hyaluronidase (rHuPH20) in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Dose-Ranging, Pharmacokinetic (PK), Glucodynamic (GD), Safety and Tolerability Study of Subcutaneously (SC) Administered Humulin R and Humalog With or Without rHuPH20
Updated: 12/31/1969
A Phase I, Randomized, Dose-Ranging, Pharmacokinetic, Glucodynamic, Safety, and Tolerability Study of SC Administered Humulin R and Humalog With or Without Recombinant Human Hyaluronidase (rHuPH20) in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase I Study of SB26 in Healthy Volunteers
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Single and Multiple Rising Dose Study to Explore the Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of SB26 in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
A Phase I Study of SB26 in Healthy Volunteers
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled, Single and Multiple Rising Dose Study to Explore the Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of SB26 in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat
Updated: 12/31/1969
A 2-Stage, Open-Label, Randomized, Single-Dose, Crossover Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat in Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat
Updated: 12/31/1969
A 2-Stage, Open-Label, Randomized, Single-Dose, Crossover Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat in Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Implant Pharmacokinetic and Pharmacodynamic Study
Updated: 12/31/1969
A Phase Ib Study to Confirm the Pharmacokinetics and Melanogenic Potential of Controlled-Release Bioresorbable Implants of Afamelanotide in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Implant Pharmacokinetic and Pharmacodynamic Study
Updated: 12/31/1969
A Phase Ib Study to Confirm the Pharmacokinetics and Melanogenic Potential of Controlled-Release Bioresorbable Implants of Afamelanotide in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effect of PBI-4050 on the Pharmacokinetics of Midazolam in Heathy Adult Subjects
Updated: 12/31/1969
A Phase 1, Drug-Drug Interaction Study to Evaluate the Effect of PBI-4050 on the Pharmacokinetics of Midazolam, a Sensitive Cytochrome P450 3A Substrate, in Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
Effect of PBI-4050 on the Pharmacokinetics of Midazolam in Heathy Adult Subjects
Updated: 12/31/1969
A Phase 1, Drug-Drug Interaction Study to Evaluate the Effect of PBI-4050 on the Pharmacokinetics of Midazolam, a Sensitive Cytochrome P450 3A Substrate, in Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Increasing Water Access and Appeal in Community Recreation Centers
Updated: 12/31/1969
A Randomized Trial of a Comprehensive Multi-level Intervention to Increase Water Access and Appeal in Community Recreation Centers
Status: Enrolling
Updated: 12/31/1969
Increasing Water Access and Appeal in Community Recreation Centers
Updated: 12/31/1969
A Randomized Trial of a Comprehensive Multi-level Intervention to Increase Water Access and Appeal in Community Recreation Centers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Malaria: Relative Bioavailability and Food Effect of DSM265
Updated: 12/31/1969
Relative Bioavailability and Effect of Food on DSM265-TPGS 34% SDD Powder in Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
Malaria: Relative Bioavailability and Food Effect of DSM265
Updated: 12/31/1969
Relative Bioavailability and Effect of Food on DSM265-TPGS 34% SDD Powder in Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cconsumer Perspective and Understanding of the Term "Milk"
Updated: 12/31/1969
A Pilot Study Investigating Consumer Perspective and Understanding of the Term "Milk"
Status: Enrolling
Updated: 12/31/1969
Cconsumer Perspective and Understanding of the Term "Milk"
Updated: 12/31/1969
A Pilot Study Investigating Consumer Perspective and Understanding of the Term "Milk"
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study in Evaluating Bioequivalence Between Test and Reference Formulations of Vadadustat Tablets in Healthy Adults
Updated: 12/31/1969
A Randomized, Open-Label, Single-Dose, Two-Period Crossover Study in Healthy Adults to Assess Bioequivalence Between Test and Reference Formulations of Vadadustat 150 mg Tablets
Status: Enrolling
Updated: 12/31/1969
A Study in Evaluating Bioequivalence Between Test and Reference Formulations of Vadadustat Tablets in Healthy Adults
Updated: 12/31/1969
A Randomized, Open-Label, Single-Dose, Two-Period Crossover Study in Healthy Adults to Assess Bioequivalence Between Test and Reference Formulations of Vadadustat 150 mg Tablets
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Comparison of High-intensity Interval Training Protocols on Health and Fitness
Updated: 12/31/1969
A Comparison of High-intensity Interval Training Protocols on Cardiometabolic Markers, Physical Performance, and Psychosocial Markers in College Females
Status: Enrolling
Updated: 12/31/1969
A Comparison of High-intensity Interval Training Protocols on Health and Fitness
Updated: 12/31/1969
A Comparison of High-intensity Interval Training Protocols on Cardiometabolic Markers, Physical Performance, and Psychosocial Markers in College Females
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 1 Study to Evaluate ASN002 Absorption, Metabolism, and Excretion of [14C] Following a Single Oral Dose in Healthy Male Subjects
Updated: 12/31/1969
A Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C] ASN002 Following a Single Oral Dose in Healthy Male Subjects
Status: Enrolling
Updated: 12/31/1969
Phase 1 Study to Evaluate ASN002 Absorption, Metabolism, and Excretion of [14C] Following a Single Oral Dose in Healthy Male Subjects
Updated: 12/31/1969
A Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C] ASN002 Following a Single Oral Dose in Healthy Male Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of SYNT001 in Healthy Volunteers
Updated: 12/31/1969
A Phase 1a, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study of SYNT001 in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
A Study of SYNT001 in Healthy Volunteers
Updated: 12/31/1969
A Phase 1a, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study of SYNT001 in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Performance of the ID-Cap System, an Ingestion Event Marker, in the Clinical Setting as an Aid to Measure Medication Adherence
Updated: 12/31/1969
Performance of the ID-Cap System, in the Clinical Setting as an Aid to Measure Medication Adherence (DO Trial 2.0)
Status: Enrolling
Updated: 12/31/1969
Performance of the ID-Cap System, an Ingestion Event Marker, in the Clinical Setting as an Aid to Measure Medication Adherence
Updated: 12/31/1969
Performance of the ID-Cap System, in the Clinical Setting as an Aid to Measure Medication Adherence (DO Trial 2.0)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of CVN424 in Healthy Subjects
Updated: 12/31/1969
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetic Study of Escalating Single and Multiple Doses of CVN424 in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Study of CVN424 in Healthy Subjects
Updated: 12/31/1969
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetic Study of Escalating Single and Multiple Doses of CVN424 in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study in Evaluating Bioequivalence of Test and Reference Vadadustat 450 MG and 150 MG Tablets and to Determine Food Effect on the 450 MG Tablet
Updated: 12/31/1969
A Randomized, Open-Label, Single-Dose, Three-Period Six-Sequence Crossover Study in Healthy Adults to Assess Bioequivalence Between Test and Reference Vadadustat 450 mg and 150 mg Tablets and to Determine Food Effect on the 450 mg Vadadustat Tablet.
Status: Enrolling
Updated: 12/31/1969
A Study in Evaluating Bioequivalence of Test and Reference Vadadustat 450 MG and 150 MG Tablets and to Determine Food Effect on the 450 MG Tablet
Updated: 12/31/1969
A Randomized, Open-Label, Single-Dose, Three-Period Six-Sequence Crossover Study in Healthy Adults to Assess Bioequivalence Between Test and Reference Vadadustat 450 mg and 150 mg Tablets and to Determine Food Effect on the 450 mg Vadadustat Tablet.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of Nephure™, and the Reduction of Dietary Oxalate, in Healthy Volunteers
Updated: 12/31/1969
A Prospective, Double-Blind, Randomized, Placebo-Controlled, Cross-Over Study With Nephure™, an Orally Administered Oxalate Reducing Enzyme
Status: Enrolling
Updated: 12/31/1969
Evaluation of Nephure™, and the Reduction of Dietary Oxalate, in Healthy Volunteers
Updated: 12/31/1969
A Prospective, Double-Blind, Randomized, Placebo-Controlled, Cross-Over Study With Nephure™, an Orally Administered Oxalate Reducing Enzyme
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Two Formulations of LY3074828 in Healthy Participants
Updated: 12/31/1969
A Safety, Tolerability, and Pharmacokinetic Study of Injections of LY3074828 Solution Using Investigational 1-mL Pre-filled Syringes and Investigational 2-mL Autoinjector in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
A Study of Two Formulations of LY3074828 in Healthy Participants
Updated: 12/31/1969
A Safety, Tolerability, and Pharmacokinetic Study of Injections of LY3074828 Solution Using Investigational 1-mL Pre-filled Syringes and Investigational 2-mL Autoinjector in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Extension Study to Further Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of Ozanimod and Active Metabolites
Updated: 12/31/1969
A Phase 1, Multi-center, Extension Study to Further Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of Ozanimod and Active Metabolites in Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
Extension Study to Further Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of Ozanimod and Active Metabolites
Updated: 12/31/1969
A Phase 1, Multi-center, Extension Study to Further Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of Ozanimod and Active Metabolites in Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Extension Study to Further Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of Ozanimod and Active Metabolites
Updated: 12/31/1969
A Phase 1, Multi-center, Extension Study to Further Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of Ozanimod and Active Metabolites in Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
Extension Study to Further Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of Ozanimod and Active Metabolites
Updated: 12/31/1969
A Phase 1, Multi-center, Extension Study to Further Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of Ozanimod and Active Metabolites in Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Smart Sleep In-home Validation Extension Study
Updated: 12/31/1969
Smart Sleep In-home Validation Extension Study
Status: Enrolling
Updated: 12/31/1969
Smart Sleep In-home Validation Extension Study
Updated: 12/31/1969
Smart Sleep In-home Validation Extension Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of OP-101 After Intravenous Administration in Healthy Volunteers
Updated: 12/31/1969
A Phase 1 Open-Label Single-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of OP-101 (Dendrimer N-Acetyl-Cysteine) After Intravenous Administration in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of OP-101 After Intravenous Administration in Healthy Volunteers
Updated: 12/31/1969
A Phase 1 Open-Label Single-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of OP-101 (Dendrimer N-Acetyl-Cysteine) After Intravenous Administration in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Subcutaneous Hydration Enabled by Human Recombinant Hyaluronidase (Hylenex)
Updated: 12/31/1969
The INcreased Flow Utilizing Subcutaneously-Enabled Normal Saline and Lactated Ringer's (INFUSE-NSLR) Study: A Phase IV, Double-Blind, Randomized Study of Subcutaneous Hydration Enabled by Human Recombinant Hyaluronidase (Hylenex) in Volunteer Subjects
Status: Enrolling
Updated: 12/31/1969
Study of Subcutaneous Hydration Enabled by Human Recombinant Hyaluronidase (Hylenex)
Updated: 12/31/1969
The INcreased Flow Utilizing Subcutaneously-Enabled Normal Saline and Lactated Ringer's (INFUSE-NSLR) Study: A Phase IV, Double-Blind, Randomized Study of Subcutaneous Hydration Enabled by Human Recombinant Hyaluronidase (Hylenex) in Volunteer Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Determine the Bioavailability and Food Effect of a Single TAK-935 Dose in Healthy Participants
Updated: 12/31/1969
A Phase 1 Bioavailability and Food Effect Study to Compare Tablet Versus Solution Formulation and to Assess the Effect of Food on the Bioavailability of a Single TAK-935 Dose in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
A Study to Determine the Bioavailability and Food Effect of a Single TAK-935 Dose in Healthy Participants
Updated: 12/31/1969
A Phase 1 Bioavailability and Food Effect Study to Compare Tablet Versus Solution Formulation and to Assess the Effect of Food on the Bioavailability of a Single TAK-935 Dose in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Plethysmographic and Acoustic Respiration Rate Clinical Data Collection
Updated: 12/31/1969
Plethysmographic and Acoustic Respiration Rate Clinical Data Collection
Status: Enrolling
Updated: 12/31/1969
Plethysmographic and Acoustic Respiration Rate Clinical Data Collection
Updated: 12/31/1969
Plethysmographic and Acoustic Respiration Rate Clinical Data Collection
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MA-0211 in Healthy Adult Subjects Including a Food Effect Cohort
Updated: 12/31/1969
A Phase 1 Combined Single and Multiple Ascending Oral Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MA-0211 in Healthy Adult Subjects Including a Food Effect Cohort
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MA-0211 in Healthy Adult Subjects Including a Food Effect Cohort
Updated: 12/31/1969
A Phase 1 Combined Single and Multiple Ascending Oral Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MA-0211 in Healthy Adult Subjects Including a Food Effect Cohort
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Performance Equivalence of Rainbow Acoustic Monitoring (RAM) Small Sensor and RAM Revision D Sensor
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Performance Equivalence of Rainbow Acoustic Monitoring (RAM) Small Sensor and RAM Revision D Sensor
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Accuracy of Acoustic Rainbow Monitoring (ARM) Sensor
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Accuracy of Acoustic Rainbow Monitoring (ARM) Sensor
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Single Ascending Dose Study of PRT064445, a Factor Xa (fXa) Inhibitor Antidote
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenously Administered PRT064445, a Factor Xa (fXa) Inhibitor Antidote
Status: Enrolling
Updated: 12/31/1969
Single Ascending Dose Study of PRT064445, a Factor Xa (fXa) Inhibitor Antidote
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenously Administered PRT064445, a Factor Xa (fXa) Inhibitor Antidote
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Postprandial Glycemia in Orange Products
Updated: 12/31/1969
Effect of Added Fruit Pomace Fiber and Whole Fruit on Postprandial Glycemia in Orange
Status: Enrolling
Updated: 12/31/1969
Postprandial Glycemia in Orange Products
Updated: 12/31/1969
Effect of Added Fruit Pomace Fiber and Whole Fruit on Postprandial Glycemia in Orange
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Evaluate Whether BLI-489 Can be Safely Tolerated by Healthy Subjects Given Multiple Doses
Updated: 12/31/1969
Ascending Multiple Dose Study of the Safety, Tolerability, and Pharmacokinetics of BLI-489 Administered Intravenously to Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Study to Evaluate Whether BLI-489 Can be Safely Tolerated by Healthy Subjects Given Multiple Doses
Updated: 12/31/1969
Ascending Multiple Dose Study of the Safety, Tolerability, and Pharmacokinetics of BLI-489 Administered Intravenously to Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
D1 Receptor Occupancy (RO) Following a Single Dose of PF-06412562
Updated: 12/31/1969
An Open-Label Study To Evaluate D1 Receptor Occupancy (RO) Following a Single Dose of PF-06412562, Using Positron Emission Tomography (PET) With Ligand [18F]MNI-968 in Healthy Male Subjects
Status: Enrolling
Updated: 12/31/1969
D1 Receptor Occupancy (RO) Following a Single Dose of PF-06412562
Updated: 12/31/1969
An Open-Label Study To Evaluate D1 Receptor Occupancy (RO) Following a Single Dose of PF-06412562, Using Positron Emission Tomography (PET) With Ligand [18F]MNI-968 in Healthy Male Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effect of Venglustat in Patients With Renal Impairment
Updated: 12/31/1969
A Phase I, Single-Center, Open-label, Single Dose Pharmacokinetic and Tolerability Study of GZ402671 in Subjects With Mild, Moderate and Severe Renal Impairment, and in Matched Subjects With Normal Renal Function
Status: Enrolling
Updated: 12/31/1969
Effect of Venglustat in Patients With Renal Impairment
Updated: 12/31/1969
A Phase I, Single-Center, Open-label, Single Dose Pharmacokinetic and Tolerability Study of GZ402671 in Subjects With Mild, Moderate and Severe Renal Impairment, and in Matched Subjects With Normal Renal Function
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Healthy Volunteers Study to Estimate the Effects of Food on the Bioavailability of Oxycodone and Naltrexone/6- Β -Naltrexol From a Extended Release Formulation of Oxycodone With Sequestered Naltrexone
Updated: 12/31/1969
An Open-Label, Single-Dose, Randomized, Three-Way Crossover Study in Healthy Volunteers to Estimate the Effects of Food and of Sprinkling ALO-02 Pellets on Applesauce on the Bioavailability of Oxycodone and Naltrexone/6- Β -Naltrexol From a Extended Release Pellets-in-Capsule Formulation of Oxycodone 40 Mg With Sequestered Naltrexone 4.8 Mg
Status: Enrolling
Updated: 12/31/1969
Healthy Volunteers Study to Estimate the Effects of Food on the Bioavailability of Oxycodone and Naltrexone/6- Β -Naltrexol From a Extended Release Formulation of Oxycodone With Sequestered Naltrexone
Updated: 12/31/1969
An Open-Label, Single-Dose, Randomized, Three-Way Crossover Study in Healthy Volunteers to Estimate the Effects of Food and of Sprinkling ALO-02 Pellets on Applesauce on the Bioavailability of Oxycodone and Naltrexone/6- Β -Naltrexol From a Extended Release Pellets-in-Capsule Formulation of Oxycodone 40 Mg With Sequestered Naltrexone 4.8 Mg
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effect of Copanlisib on Metformin PK and PD
Updated: 12/31/1969
An Open-label, Non-randomized, Phase I Study to Evaluate the Effect of Copanlisib (a Single Intravenous Dose of 60 mg) on the Pharmacokinetics (PK) and Pharmacodynamics (PD) of Metformin (MATE2-K Substrate) in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Effect of Copanlisib on Metformin PK and PD
Updated: 12/31/1969
An Open-label, Non-randomized, Phase I Study to Evaluate the Effect of Copanlisib (a Single Intravenous Dose of 60 mg) on the Pharmacokinetics (PK) and Pharmacodynamics (PD) of Metformin (MATE2-K Substrate) in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of LY2484595 in Healthy Subjects
Updated: 12/31/1969
Single Dose LY2484595 Tablet Formulations to Determine the Impact of Dose Level, Food, and Ethnicity on the Pharmacokinetics in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
A Study of LY2484595 in Healthy Subjects
Updated: 12/31/1969
Single Dose LY2484595 Tablet Formulations to Determine the Impact of Dose Level, Food, and Ethnicity on the Pharmacokinetics in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Evacetrapib in Healthy Participants
Updated: 12/31/1969
Effect of Gemfibrozil on the Pharmacokinetics of Evacetrapib (LY2484595) in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
A Study of Evacetrapib in Healthy Participants
Updated: 12/31/1969
Effect of Gemfibrozil on the Pharmacokinetics of Evacetrapib (LY2484595) in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Compare the Pharmacokinetic of K-877 Controlled Release (CR) and Immediate Release (IR) Tablets in Healthy Adults.
Updated: 12/31/1969
Single-Dose, Randomized, Open-Label, 4-Period, 4-Sequence Crossover Study of Three Prototypes of K-877 CR Tablet and Two K-877 Tablets Administered to Healthy Adult Volunteers
Status: Enrolling
Updated: 12/31/1969
Compare the Pharmacokinetic of K-877 Controlled Release (CR) and Immediate Release (IR) Tablets in Healthy Adults.
Updated: 12/31/1969
Single-Dose, Randomized, Open-Label, 4-Period, 4-Sequence Crossover Study of Three Prototypes of K-877 CR Tablet and Two K-877 Tablets Administered to Healthy Adult Volunteers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Evaluate the Absorption, Distribution, Metabolism, Excretion and Absolute Bioavailability of AG-348 in Healthy Male Participants Following Administration of a Single Oral Dose of [14C]AG-348 and Concomitant Single Intravenous Microdose of [13C6]AG-348
Updated: 12/31/1969
A Phase I, Open-label Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion and to Assess the Absolute Bioavailability of AG-348 in Healthy Male Subjects Following Administration of a Single Oral Dose of [14C]AG-348 and Concomitant Single Intravenous Microdose of [13C6]AG-348
Status: Enrolling
Updated: 12/31/1969
A Study to Evaluate the Absorption, Distribution, Metabolism, Excretion and Absolute Bioavailability of AG-348 in Healthy Male Participants Following Administration of a Single Oral Dose of [14C]AG-348 and Concomitant Single Intravenous Microdose of [13C6]AG-348
Updated: 12/31/1969
A Phase I, Open-label Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion and to Assess the Absolute Bioavailability of AG-348 in Healthy Male Subjects Following Administration of a Single Oral Dose of [14C]AG-348 and Concomitant Single Intravenous Microdose of [13C6]AG-348
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effects Of Ingesting An Energy Bar On Performance And Recovery
Updated: 12/31/1969
Effects Of Ingesting A Low Glycemic Whey Protein Energy Bar Prior, During And Following Resistance Exercise And Conditioning On Performance And Recovery
Status: Enrolling
Updated: 12/31/1969
Effects Of Ingesting An Energy Bar On Performance And Recovery
Updated: 12/31/1969
Effects Of Ingesting A Low Glycemic Whey Protein Energy Bar Prior, During And Following Resistance Exercise And Conditioning On Performance And Recovery
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pharmacokinetics of Oral Mirabegron With Different Release Rates Versus Intravenous (IV) Mirabegron
Updated: 12/31/1969
A Phase 1, Open-Label, Randomized, Parallel Dose Group Study to Assess the Pharmacokinetics of Mirabegron OCAS Formulations With Different Release Rates Versus IV Infusion in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Pharmacokinetics of Oral Mirabegron With Different Release Rates Versus Intravenous (IV) Mirabegron
Updated: 12/31/1969
A Phase 1, Open-Label, Randomized, Parallel Dose Group Study to Assess the Pharmacokinetics of Mirabegron OCAS Formulations With Different Release Rates Versus IV Infusion in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocannabinoid and Psychological Responses to Yoga in Healthy Adults
Updated: 12/31/1969
Endocannabinoid and Psychological Responses to Yoga in Healthy Adults
Status: Enrolling
Updated: 12/31/1969
Endocannabinoid and Psychological Responses to Yoga in Healthy Adults
Updated: 12/31/1969
Endocannabinoid and Psychological Responses to Yoga in Healthy Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Norketotifen in Healthy Subjects
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled, 2-Part, Single Ascending Dose and Multiple Dose Cohort Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Norketotifen in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Norketotifen in Healthy Subjects
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled, 2-Part, Single Ascending Dose and Multiple Dose Cohort Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Norketotifen in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate the Safety, Tolerability, & Pharmacokinetics of K-285 Compared With Indomethacin Capsule in Healthy Adults
Updated: 12/31/1969
A Phase I, Open-label, Randomized, 4-period Crossover Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of K-285 Compared With a Single Oral Dose of Indomethacin Capsule in Healthy Adult Volunteers
Status: Enrolling
Updated: 12/31/1969
Evaluate the Safety, Tolerability, & Pharmacokinetics of K-285 Compared With Indomethacin Capsule in Healthy Adults
Updated: 12/31/1969
A Phase I, Open-label, Randomized, 4-period Crossover Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of K-285 Compared With a Single Oral Dose of Indomethacin Capsule in Healthy Adult Volunteers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Effects of Ellagic Acid From Pomegranate Juice vs. Pure Ellagic Acid on Healthy Male Subjects
Updated: 12/31/1969
Exploratory Study to Determine the Bioavailability and Metabolism of Ellagic Acid From Pomegranate Juice vs. Pure Ellagic Acid
Status: Enrolling
Updated: 12/31/1969
The Effects of Ellagic Acid From Pomegranate Juice vs. Pure Ellagic Acid on Healthy Male Subjects
Updated: 12/31/1969
Exploratory Study to Determine the Bioavailability and Metabolism of Ellagic Acid From Pomegranate Juice vs. Pure Ellagic Acid
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Drug Interaction Study of CT1812 in Healthy Volunteers
Updated: 12/31/1969
A Fixed-Sequence Trial to Examine the Effect of Multiple-Dose CT1812 Administration on Standard Probes of CYP2C19 (Omeprazole), CYP2C9 (Tolbutamide), CYP2D6 (Dextromethorphan), and CYP3A4/5 (Midazolam) Activity in Healthy Adult Volunteers
Status: Enrolling
Updated: 12/31/1969
Drug Interaction Study of CT1812 in Healthy Volunteers
Updated: 12/31/1969
A Fixed-Sequence Trial to Examine the Effect of Multiple-Dose CT1812 Administration on Standard Probes of CYP2C19 (Omeprazole), CYP2C9 (Tolbutamide), CYP2D6 (Dextromethorphan), and CYP3A4/5 (Midazolam) Activity in Healthy Adult Volunteers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials